Mercer Global Advisors
AMED

Mercer Global Advisors’s Amedisys AMED Stock Holding History

Mercer Global Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,497
Closed -$396K – 1670
2021
Q1 		$396K Buy
+1,497
New +$422K ﹤0.01% 1186
2020
Q1 		– Sell
-2,124
Closed -$355K – 1102
2019
Q4 		$355K Sell
2,124
-541
-20% -$80.5K 0.01% 854
2019
Q3 		$349K Sell
2,665
-475
-15% -$61.8K 0.01% 841
2019
Q2 		$381K Buy
+3,140
New +$373K 0.01% 781

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Mercer Global Advisors's AMED Position: Q2 2021 in Review

Mercer Global Advisors sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,497 shares — an estimated $396K sold.

Mercer Global Advisors first reported a position in AMED in Q2 2019 and held it in 4 quarters. The position peaked at $396K in Q1 2021. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Mercer Global Advisors reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Mercer Global Advisors sold 1,497 Amedisys shares in Q2 2021, an estimated $396K.
  • Mercer Global Advisors first reported a position in Amedisys in Q2 2019 and held it in 4 quarters.
  • Mercer Global Advisors's Amedisys position peaked at $396K in Q1 2021.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Mercer Global Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.